| A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) (NCT05429320) | Memorial Sloan Kettering Cancer Center | 2022-06-15 |
| Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD) (NCT04604691) | Seoul National University Hospital | 2022-02-18 |
| A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment (NCT06109233) | FengYan Jin | 2022-01-10 |
| Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation (NCT05460195) | Shanghai Chest Hospital | 2022-01-01 |
| Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD (NCT05408897) | Peking University People's Hospital | 2022-01-01 |
| Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD (NCT05137860) | Hospital General de Mexico | 2021-12-12 |
| A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (NCT04853017) | Elicio Therapeutics | 2021-10-04 |
| Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia (NCT05093192) | University of Bath | 2021-10-01 |
| Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML) (NCT04920188) | UNC Lineberger Comprehensive Cancer Center | 2021-05-28 |
| Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients (NCT06885476) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-01-22 |
| Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat (NCT04712942) | University of Leipzig | 2021-01-01 |
| ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT (NCT04785547) | Prof. Christina Peters | 2020-12-17 |
| Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies (NCT03272633) | Rutgers, The State University of New Jersey | 2020-10-26 |
| Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant (NCT03537599) | Sumithira Vasu | 2020-01-10 |
| Better Leukemia Diagnostics Through AI (BELUGA) (NCT04466059) | Munich Leukemia Laboratory | 2020-01-05 |
| Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease (NCT03516279) | ECOG-ACRIN Cancer Research Group | 2019-06-26 |
| Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma (NCT04029038) | M.D. Anderson Cancer Center | 2019-05-15 |
| Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD) (NCT03699384) | Memorial Sloan Kettering Cancer Center | 2018-10-03 |
| The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML (NCT03665480) | Nanfang Hospital, Southern Medical University | 2018-09-04 |
| Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants (NCT03624530) | Nanfang Hospital, Southern Medical University | 2018-08-01 |
| Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03494569) | City of Hope Medical Center | 2018-07-06 |
| HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant (NCT03326921) | Fred Hutchinson Cancer Center | 2018-02-23 |
| Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies (NCT03241940) | Stanford University | 2017-10-20 |
| Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma (NCT03096782) | M.D. Anderson Cancer Center | 2017-10-13 |
| CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies (NCT03233854) | Stanford University | 2017-09-01 |
| Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03192397) | Roswell Park Cancer Institute | 2017-08-09 |
| Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant (NCT03297528) | Peking University People's Hospital | 2017-03-01 |
| Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia (NCT02767934) | University of Washington | 2017-01-13 |
| MRD-directed Therapy for Low-risk and Intermediate-risk AML. (NCT02870777) | Nanfang Hospital, Southern Medical University | 2016-08-01 |
| MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT (NCT02673008) | Nanfang Hospital, Southern Medical University | 2016-01-01 |
| CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies (NCT02529813) | M.D. Anderson Cancer Center | 2015-12-16 |
| Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT02159495) | City of Hope Medical Center | 2015-12-15 |
| Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease (NCT02458014) | M.D. Anderson Cancer Center | 2015-09-14 |
| Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia (NCT02714790) | A.O.U. Città della Salute e della Scienza | 2015-05-01 |
| Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors (NCT02400827) | University Hospital, Clermont-Ferrand | 2014-11-01 |
| Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors (NCT02400970) | University Hospital, Clermont-Ferrand | 2014-11-01 |
| Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT01894477) | Fred Hutchinson Cancer Center | 2013-11-01 |
| Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors (NCT01751425) | M.D. Anderson Cancer Center | 2013-07-24 |
| TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (NCT01883219) | Nanfang Hospital, Southern Medical University | 2013-06-01 |
| Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues (NCT02900625) | Centre Hospitalier Universitaire de Besancon | 2013-05-01 |
| Caris Biorepository Research Protocol (NCT01499394) | Caris Science, Inc. | 2010-11-01 |
| Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia (NCT01158885) | Therapeutic Advances in Childhood Leukemia Consortium | 2010-08-01 |
| Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease (NCT00267085) | M.D. Anderson Cancer Center | 2005-12-01 |